Suppr超能文献

抗糖尿病药物的抗氧化潜力:一种可能的保护机制,可预防糖尿病患者的血管并发症。

Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients.

机构信息

Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Life Sciences Research Division, Anti-Doping Laboratory Qatar, Doha, Qatar.

出版信息

J Cell Physiol. 2019 Mar;234(3):2436-2446. doi: 10.1002/jcp.27278. Epub 2018 Sep 7.

Abstract

Many vascular complications are related to exposure of tissues to elevated levels of glucose, a condition that promotes oxidative stress. The primary goal of antidiabetic medication is for normalization of blood glucose. However, antidiabetic medications may have antioxidant effects that go beyond their hypoglycemic influences. Therefore, antidiabetic drugs may be doubly beneficial in preventing diabetic complications. Vascular dysfunction due to uncontrolled diabetes is a serious complication of the disease and one which has a severe impact on quality of life. Readjustment of the oxidative balance in subjects with diabetes, and the positive effects thereof is a topic of intense interest at present. In the current review, we highlight the antioxidant effects of antidiabetic medications which may prevent or delay the onset of vascular dysfunction.

摘要

许多血管并发症与组织暴露于高浓度葡萄糖有关,这种情况会促进氧化应激。抗糖尿病药物的主要目标是使血糖正常化。然而,抗糖尿病药物可能具有超越其降血糖作用的抗氧化作用。因此,抗糖尿病药物在预防糖尿病并发症方面可能具有双重益处。由于糖尿病控制不佳导致的血管功能障碍是该疾病的严重并发症,对生活质量有严重影响。目前,调整糖尿病患者的氧化平衡及其积极影响是一个非常感兴趣的话题。在当前的综述中,我们强调了抗糖尿病药物的抗氧化作用,这些作用可能预防或延迟血管功能障碍的发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验